Cytokinetics, Inc. (CYTK)
61.60
-2.53
(-3.95%)
USD |
NASDAQ |
Dec 09, 16:00
62.06
+0.46
(+0.75%)
Pre-Market: 08:52
Cytokinetics Market Cap: 7.532B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Jasper Therapeutics, Inc. | 49.53M |
| Lantheus Holdings, Inc. | 4.037B |
| Bristol Myers Squibb Co. | 103.11B |
| Pfizer Inc. | 144.02B |
| Regeneron Pharmaceuticals, Inc. | 72.79B |
Market Cap Related Metrics
| PS Ratio | 84.06 |
| PEG Ratio | -0.5716 |
| Price | 61.60 |
| Earnings Yield | -10.24% |
| PEGY Ratio | -0.5716 |